Wuhan Newfoss Biotechnology Co., Ltd., established on 2016-07-11, Business scope includes biological products,Instrumentation(Does not include measuring instruments),laboratory reagent(Does not contain dangerous goods),gene medicine,Development of genetic diagnostic kits,Production and Wholesale and Retail;Technology R&D in Bioengineering,Technical Services,technology transfer;Biotechnology Consulting;Import and export,Technology Import and Export,Agent import and export(Goods and technologies prohibited or restricted from import and export by the state are not included).(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Gencia, LLC operates as a biotechnology company. The company was founded in 2002 and is based in Charlottesville, Virginia.

UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including University College Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.

UK Research & Innovation (doing business as United Kingdom Research & Innovation) is a private company headquartered in London, UK. The firm provides science and technology research services.\nThe company says this about itself: Innovate UK is part of UK Research and Innovation, a non-departmental public body funded by a grant-in-aid from the UK government. We drive productivity and economic growth by supporting businesses to develop and realise the potential of new ideas, including those from the UK’s world-class research base.

At the beginning of the twentieth century, tuberculosis was one of the UK’s most urgent health problems. A royal commission, entitled The Royal Commission Appointed to Inquire into the Relations of Human and Animal Tuberculosis, was set up in 1901. It aimed to find out whether tuberculosis in animals and humans was the same disease and whether animals and humans could infect each other. This page describes how, by 1919, the Commission had evolved into the independent Medical Research Council.

ICCAS was founded in 1956. ICCAS is a multi-disciplinary research institute dedicated to the basic research in broad fields of chemical sciences, and to the key developments of the innovative high technologies aiming to the imperative national needs and important strategic targets, as well as to the collaborative high-technology applications and transfers. ICCAS is one of China’s leading chemistry research institutions with high international reputation.

Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.

Manufactures pharmaceuticals

MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA

Sanofi A/S engages in the production of prescription drugs as well as participates in clinical trials of present and future products. It specializes in diabetes, oncology, multiple sclerosis, rare disease and cardio vascular illnesses. The company is headquartered in Copenhagen, Denmark.

Mitotech S.A. is a Luxembourg-based single-molecule biotechnology company with a portfolio of novel drugs for the treatment of age-related disorders undergoing early, middle and late stages of drug development. Their drug portfolio consists of an ophthalmic drug (Visomitin™) and a systemic drug (Plastomitin™) that both have their lead compound SkQ1 – a highly efficient mitochondria-targeted antioxidant – as their active ingredient. Their core team is a unique fusion of cross-disciplinary scientific experts, seasoned clinical drug development professionals and experienced business managers. Using this blend of business skills, industry expertise and fundamental scientific knowledge their company aims to approach complex scientific problems, such as protection against cellular oxidative stress, and turn the results of biological research into a line-up of pharmaceutical products. Company’s mission is to leverage the break-through in delivering highly active antioxidants into mitochondria across a wide spectrum of age-related therapeutic indications and to deliver medications with this novel mechanism of action to millions of patients worldwide.

Lanrun Environmental Technology (Yantai) Co., Ltd., established on 2021-11-24, Business scope includes general items:Environmental Consulting Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;water pollution control;Air Pollution Control;Soil Environmental Pollution Prevention and Control Services;Emerging energy technology research and development;software development;Computer System Services;Solid Waste Treatment;Solar Power Technology Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Construction Engineering Construction;Hazardous Waste Management.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

The Boyce Thompson Institute (previously: Boyce Thompson Institute for Plant Research) is an independent research institute devoted to using plant sciences to improve agriculture, protect the environment, and enhance human health. BTI is located on the campus of Cornell University in Ithaca, New York, United States, and is fully integrated in the research infrastructure of the University. Faculty at BTI are members of several Cornell Departments, including Plant Biology, Chemistry & Chemical Biology, Molecular Biology & Genetics, as well as Plant Pathology and Plant-Microbe Biology. BTI is governed by a Board of Directors, which is in part appointed by Cornell.

Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. The company was founded on April 3, 2006 and is headquartered in Needham, MA.

Changzhou Rydows Biomedical Technology Co., Ltd., established on 2013-01-04, Business scope includes technical development of biological products,technology transfer,Technical training and technical services;Class I medical device,chemical reagent,chemical intermediate,Edible produce,sales of cosmetics;R&D and sales of electronic equipment;Wholesale and retail of prepackaged food.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)